Innovative solutions to the greatest challenges in pharmaceutical development

21 - 23 March 2022

The AGENDA for the 13th Global Drug Delivery & Formulation Summit is now live!

The 2022 Summit covers small molecules and biologicsnew technologies, concepts and case studies in areas such as:

  • Formulation design for poorly soluble compounds
  • The potential of nanotechnology for better deliverability
  • The latest controlled released technologies
  • Improving patient compliance by harnessing data and the latest smart device technology
  • Optimising formulations for continuous manufacturing
  • Overcoming the blood brain barrier and challenges in oral delivery of biologics
  • Reformulation and biosimilars

BOOK FOR €995

2022 Speakers

Steve Amoussou-Guenou

Roquette

Global Technical Developer

Sune Andersen

Janssen

Principal Scientist in Particle Engineering

Jean-Rene Authelin

Sanofi

Global Head of Pharmaceutical Engineering

Vimalkumar Balasubramanian

Bayer

Senior Scientist/ Science Fellow

Dr. Fatima Bennai-Sanfourche

Bayer

Director Medical Device Safety, Medical Device Safety Officer

Dr. Andreas Bernkop-Schnürch

Innsbruck University

Head of the Department Center for Chemistry and Biomedicine

Beate Bittner

Roche

Senior Portfolio Strategy Director

Michael Black

Beneo

Head of Sales Pharma

Jeffrey T. Blue

MSD

Executive Director, Vaccine Drug Product Development PR&D

Joshua Boateng

University of Greenwich

Professor in Pharmaceutics and Drug Delivery, School of Science

Dr. Stefan Bracht

Bayer

Vice President Head of Disruptive Technologies

Stephen Buckley

Novo Nordisk

Director, Oral Delivery Technologies

Jinling Chen

STA Pharmaceutical

SVP, Pharmaceutical Development Services

Stefanie Dohrn

AbbVie

Senior Scientist

Naila El-kechai

Sanofi

Formulation and Drug Product Team Leader

Paulina Luisa Fischer

AbbVie

PhD Student

Patrick Garidel

Boehringer Ingelheim

Head of Process, Purification and Pharma Development

Vanessa Havenith

SE Tylose GmbH & Co. KG

Technical Sales Manager

Helen Hao Hou

Genentech

Principal Scientist Small Molecule Pharmaceutical Sciences

Ben Van Hove

Janssen

Associate Director Drug Product Development, Oral Solid Dosage Forms

Martin Huelsmeyer

AbbVie

Head of HTS Operations & Analytics

James Humphrey

Croda

Research & Technology Specialist

Pauline Janssen

DFE Pharma

Product Application Specialist

Ajay J. Khopade

Sun Pharma Advanced Research

Vice President-R&D, Formulation Development (Non-Orals)

Samuel Kyeremateng

Abbvie

NCE Formulation Sciences Senior Scientist

Claus-Michael Lehr

Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)

Head, Dept. of Drug Delivery (DDEL)

Philippe Lienard

Sanofi

Early Development Coordinator

Christian Lotz

Pfanstiehl GmbH

General Manager EMEA

Dr. Manfred Ogris

University of Vienna

Professor Department of Pharmaceutical Sciences

Heinrich Martens

Fresenius Kabi

Vice President Regulatory Affairs - BU Devices Pharmaceuticals and Devices Division

Salvatore Mercuri

Lonza

Associate Director, NPI & MSAT, Monteggio

Mikolaj Milewski

MSD

Principal Scientist

Valentyn Mohylyuk

Queen's University Belfast

Pharmaceutical Scientist (research fellow)

Anette Müllertz

University of Copenhagen

Professor, Head of Center

Mostafa Nakach

Sanofi

Head of formulation and Process Development

Rene Van Nostrum

Utrecht University

Associate Professor, Pharmaceutical Sciences

Rick Panicucci

QED

Senior Vice President CMC

Charles Rampersaud

Genentech

Vice President, Head of Device and Combination Products

John C. Shelley

Schrödinger

Fellow

Corinna Sonderegger

Novartis

Executive Director Competence Center, Global Device & Packaging Development (GDPD)

Vivek Trivedi

University of Kent

Lecturer in Drug Delivery, Medway School of Pharmacy

Driton Vllasaliu

King’s College London

Senior Lecturer in Pharmaceutics

Matthias Gerhard Wacker

National University of Singapore

Associate Professor

Kerstin Walke

Boehringer Ingelheim

Head of Pharmaceutical Development Biologicals

×

Latest News

Nanoform’s Clinical Study Indicates Positive Interim Results

Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announced positive interim results from its clinical study. The faster absorption data implies that small particles can indeed be powerful.

Silicones for drug infusion devices - From hospital to wearable: how silicones are used at different scales to help patients live a normal life

This e-book presents an overview of the medical, industrial, compliance and economic advantages and challenges in the use of silicone materials in Infusion as a method of drug delivery. The unique properties of silicones along with their longstanding, proven track record in medical applications, can enable innovative solutions that improve the quality and efficacy of infusion care.

PMC Isochem To accelerate Polyamino acids Business as part of ISODEL® Drug Delivery offer, a unique One Stop Shop for NCA and PAA

PMC Isochem announces today that it is accelerating the strategic development and manufacture of polyamino acids (PAA) as functional excipients used in complex formulations and drug delivery solutions. Based on its own internal resources and endowed with a fully integrated know-how as well as its leading position in the manufacture of critical Activated Amino Acids (NCA), PMC Isochem becomes the reliable supplier of PAA and the sustainable partner.